BD Anti-HLA-DR (L243) - HSA Registration DE0510228
Access comprehensive regulatory information for BD Anti-HLA-DR (L243) in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0510228 and owned by Becton, Dickinson & Company. The device was registered on January 09, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Anti–HLA-DR (L243) is intended for in vitro diagnostic use in the identification of cells expressing the HLA- DR antigen in peripheral blood, using a BD FACSLyric™ flow cytometer. Clinical Applications: Expression of the HLA-DR antigen in the characterization of subjects having, or suspected of having, hematological neoplasia. Anti–HLA-DR (L243) is a qualitative reagent intended for laboratory professional use only